ACP-ESM: A novel framework for classification of anticancer peptides using protein-oriented transformer approach

Zeynep Hilal Kilimci,Mustafa Yalcin

2024-01-04

Abstract:Anticancer peptides (ACPs) are a class of molecules that have gained significant attention in the field of cancer research and therapy. ACPs are short chains of amino acids, the building blocks of proteins, and they possess the ability to selectively target and kill cancer cells. One of the key advantages of ACPs is their ability to selectively target cancer cells while sparing healthy cells to a greater extent. This selectivity is often attributed to differences in the surface properties of cancer cells compared to normal cells. That is why ACPs are being investigated as potential candidates for cancer therapy. ACPs may be used alone or in combination with other treatment modalities like chemotherapy and radiation therapy. While ACPs hold promise as a novel approach to cancer treatment, there are challenges to overcome, including optimizing their stability, improving selectivity, and enhancing their delivery to cancer cells, continuous increasing in number of peptide sequences, developing a reliable and precise prediction model. In this work, we propose an efficient transformer-based framework to identify anticancer peptides for by performing accurate a reliable and precise prediction model. For this purpose, four different transformer models, namely ESM, ProtBert, BioBERT, and SciBERT are employed to detect anticancer peptides from amino acid sequences. To demonstrate the contribution of the proposed framework, extensive experiments are carried on widely-used datasets in the literature, two versions of AntiCp2, cACP-DeepGram, ACP-740. Experiment results show the usage of proposed model enhances classification accuracy when compared to the state-of-the-art studies. The proposed framework, ESM, exhibits 96.45 of accuracy for AntiCp2 dataset, 97.66 of accuracy for cACP-DeepGram dataset, and 88.51 of accuracy for ACP-740 dataset, thence determining new state-of-the-art.

Biomolecules,Artificial Intelligence,Computational Engineering, Finance, and Science,Machine Learning

What problem does this paper attempt to address?

The paper attempts to address the problem of classifying anticancer peptides (ACPs) in cancer treatment. Specifically, the paper proposes a new protein-oriented transformer approach framework—ACP-ESM, for accurately identifying anticancer peptides from amino acid sequences. This framework utilizes four different transformer models: ESM, ProtBert, BioBERT, and SciBERT, and has been validated using extensive datasets such as AntiCp2, cACP-DeepGram, and ACP-740. Experimental results show that this framework significantly outperforms existing techniques in terms of classification accuracy. In particular, the ESM model achieved accuracies of 96.45%, 97.66%, and 88.51% on these datasets, respectively, thus establishing new benchmarks. The main contribution of the paper lies in introducing an efficient transformer framework, demonstrating the potential of deep learning techniques in this field, and showcasing its performance advantages through comparative analysis of multiple models. Furthermore, the robust performance of this framework on multiple commonly used datasets proves its generality and adaptability.

ACP-ESM: A novel framework for classification of anticancer peptides using protein-oriented transformer approach

ACP-ESM2: The Prediction of Anticancer Peptides Based on Pre-trained Classifier

An efficient consolidation of word embedding and deep learning techniques for classifying anticancer peptides: FastText+BiLSTM

ACP-ML: A sequence-based method for anticancer peptide prediction

To Assist Oncologists: An Efficient Machine Learning-Based Approach for Anti-Cancer Peptides Classification

Efficient Screening of Pharmacological Broad-Spectrum Anti-Cancer Peptides Utilizing Advanced Bidirectional Encoder Representation from Transformers Strategy

ACPScanner: Prediction of Anticancer Peptides by Integrated Machine Learning Methodologies

ACP-CapsPred: an explainable computational framework for identification and functional prediction of anticancer peptides based on capsule network

ACP-check: An anticancer peptide prediction model based on bidirectional long short-term memory and multi-features fusion strategy

Extended dipeptide composition framework for accurate identification of anticancer peptides

Anticancer Peptides Classification using Kernel Sparse Representation Classifier

ANNprob-ACPs: A novel anticancer peptide identifier based on probabilistic feature fusion approach

Effective identification and differential analysis of anticancer peptides

ACP-ST: An Anticancer Peptide Prediction Model Based on Learning Embedding Features and Swin-Transformer

ACPNet: A Deep Learning Network to Identify Anticancer Peptides by Hybrid Sequence Information

Prediction of anticancer peptides based on an ensemble model of deep learning and machine learning using ordinal positional encoding

Intelligent computational method for discrimination of anticancer peptides by incorporating sequential and evolutionary profiles information

LGBM-ACp: an ensemble model for anticancer peptide prediction and in silico screening with potential drug targets

Anti-Cancer Peptides Identification and Activity Type Classification with Protein Sequence Pre-training

MA‐PEP: A novel anticancer peptide prediction framework with multimodal feature fusion based on attention mechanism